April 12, 2012 9:07 AM | 1 min read
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
AstraZeneca (NYSE: AZN) today announced the availability of DUTOPROL™ (metoprolol succinate extended release/hydrochlorothiazide) Tablets, the first and only once-daily antihypertensive agent that contains the active ingredient of TOPROL-XL® (metoprolol succinate) plus a low-dose diuretic (also known as a water pill) that provides proven blood pressure lowering at 24 hours.1,2 “One in three US adults have high blood pressure, and of these patients whom are treated, approximately 36% remain uncontrolled,” said Steve Davis, Executive Director, Foundation Brands, AstraZeneca.4 “DUTOPROL may provide another treatment option for patients with hypertension. We have launched DUTOPROL so patients now have the option to receive a branded combination medicine, in a convenient, once-a-day tablet.”
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.